Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WO533 in Post-menopausal Women with Vulvovaginal Atrophy
NCT04222647Phase 2Completed
- Sponsor
- Dr. August Wolff
- Start
- Jan 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lactic acid in Vulvovaginal atrophy (VVA), sponsored by Dr. August Wolff. Started Jan 2020; status: completed.
02
Drugs
lactic acid
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT04222647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04222647.